drugset / Trial / NCT03238482

Comparing Salmeterol/Fluticasone Easyhaler and Seretide Diskus (SAIMI)

NCT03238482

Phase 1 Completed 64 enrolled Orion Corporation, Orion Pharma
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to compare absorption of salmeterol and fluticasone from Salmeterol/fluticasone Easyhaler test products to the commercially available product Seretide Diskus

Timeline

Start
2017-08-16
Primary completion
2017-12-19
Completion
2017-12-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluticasone Other / unclassified 250 ug Inhaled
Subject Salmeterol Other / unclassified 50 ug Inhaled

Indications